AI Tool Predicts Which patients with Dystonia Respond to Botox Treatment
An artificial intelligence tool called DystoniaBoTXNet predicted which patients with dystonia would benefit from botulinum toxin injections with 96.3% accuracy.
An artificial intelligence tool called DystoniaBoTXNet predicted which patients with dystonia would benefit from botulinum toxin injections with 96.3% accuracy.
TI Surgical has received U.S. FDA approval for a clinical study to assess Cortiva Allograft Dermis in breast reconstruction, a step toward obtaining FDA pre-market approval for the implants.